Press Releases | ClavystBio

Press Releases

23 Oct 2023

Portfolio

Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001 Monotherapy Trial at the European Society for Medical Oncology Congress 2023

20 Oct 2023

Portfolio

Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501

05 Oct 2023

Portfolio

65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singapore

04 Oct 2023

ClavystBio

ClavystBio Launches Node 1 to Bring Together Life Sciences Communities to Catalyse Global Human Health Solutions

27 Sep 2023

Portfolio

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

09 Aug 2023

Portfolio

Sunbird Bio Merges with Glympse Bio to Accelerate Development of Proprietary Protein-Based Diagnostic Technologies

08 Mar 2023

Portfolio

Paratus Sciences Launches with $100M Series A Financing to Develop Novel Therapeutics Based on the Unique Biology of Bats

Page

1 2 3 4 5

Stay in the Loop

Sign up to get the latest news on our innovation community and events.

Subscribe Now